Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombotic Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07095127
What this trial is testing

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Nuvig Therapeutics, Inc. 30
Not applicableNot Yet RecruitingNCT07476846
What this trial is testing

RhTPO Dose Escalation vs Eltrombopag Switch in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 112
Post-approval studies (Phase 4)UnknownNCT03998982
What this trial is testing

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 30
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Testing effectiveness (Phase 2)Looking for participantsNCT07294365
What this trial is testing

DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

Who this might be right for
Immune Thrombocytopenia (ITP)
Dizal Pharmaceuticals 60
Testing effectiveness (Phase 2)UnknownNCT04368598
What this trial is testing

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 44
Not applicableWithdrawnNCT01869049
What this trial is testing

The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University
Testing effectiveness (Phase 2)UnknownNCT05459649
What this trial is testing

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 253
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459114
What this trial is testing

TGD001 Treatment in Thrombotic Microangiopathies

Who this might be right for
Thrombotic MicroangiopathiesITP Immune-Mediated Thrombocytopenia
TargED Biopharmaceuticals B.V. 70
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT04562766
What this trial is testing

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 232
Not applicableNot Yet RecruitingNCT07212322
What this trial is testing

CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopahic Inflammatory MyopathiesAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis+4 more
Institute of Hematology & Blood Diseases Hospital, China 24
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Large-scale testing (Phase 3)UnknownNCT01763658
What this trial is testing

Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Ain Shams University 100
Early research (Phase 1)UnknownNCT04518878
What this trial is testing

Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05214391
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)WithdrawnNCT06176235
What this trial is testing

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07019545
What this trial is testing

A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Hellenic Society of Hematology 14
Testing effectiveness (Phase 2)Study completedNCT00908037
What this trial is testing

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 82
Large-scale testing (Phase 3)Ended earlyNCT04596995
What this trial is testing

Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 43
Next Page